Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (18)	8/11/2004 9:02:29 PM
From: mopgcw	Read Replies (1) \| Respond to of 588

Insiders/Lock-up impact: % are before and after offering: 5% Stockholders Oxford Bio IV affiliates 2,314,815 19.8 % 13.7 % Lonmodtagernes Dyrtidsfond 1,123,952 9.6 6.7 OrbiMed Advisors 889,009 7.6 5.3 Dansk Kapitalanlaeg Aktieselskab 859,013 7.3 5.1 Kommunernes Pensionsforsikring A/S 704,264 6.0 4.2 Federated Kaufmann Fund 686,009 5.9 4.1 ABN AMRO Ventures BV 662,391 5.7 3.9 Hambrecht & Quist 609,671 5.2 3.6 Directors and Executive Officers Uli Hacksell, Ph.D. 439,791 3.7 2.6 Mark R. Brann, Ph.D. 787,756 6.6 4.6 Thomas H. Aasen 204,635 1.7 1.2 Robert E. Davis, Ph.D. 167,359 1.4 1.0 Bo-Ragnar Tolf, Ph.D. 83,906 * * Leslie L. Iversen, Ph.D. 17,750 * * Alan G. Walton, Ph.D. 2,314,815 19.8 13.7 Carl L. Gordon, Ph.D. 889,009 7.6 5.3 Martien van Osch 662,391 5.7 3.9 Gordon Binder 555,555 4.7 3.3 Lester J. Kaplan, Ph.D. 511,500 4.4 3.0 Torsten Rasmussen 10,500 * * directors & officers (13 persons) 6,756,633 53.0% 37.9%